Home
Careers
Conferences
Directory
Genes
InDepth
Marketing
News
Reports
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
Pharmaceutical Market Trends, 2008 - 2012: key market forecasts & growth opportunities
2.
Top-10 Biotech Companies - Market Outlook, 2008-2023
3.
Competitor Analysis: Janus Kinase (JAK) Inhibitors
4.
Enzyme Replacement & Enhancement Therapies (ERT)
5.
The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)
6.
The Cancer Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
7.
Protein Therapeutics Markets
8.
European Clinical Trial Site Options: An Insiders Analysis Overview
9.
Quality for Biologics
10.
Mammography World Markets
Best Sellers:
1.
Contract Research Annual Review 2008
2.
The Pharmaceutical Wholesale and Distribution Industry Outlook and Analysis 2008
3.
The World OTC Pharmaceutical Market Analysis and Forecasts, 2008-2023
4.
Top Companies and Products in the RNA/DNA Therapy Products Market Forecasts The challenge of turning technology into therapy
5.
Orthopedics - Global Industry Guide
6.
Competitor Analysis: c-MET/HGF Inhibitors
7.
Competitor Analysis: Alzheimers Disease Antibodies
High Growth Diagnostics - Technology and Market Analyses
Genomics advances of the 1990s are now resulting in commercial products-both analyte-specific reagents (ASRs) and in vitro diagnostics (IVDs).
Report Overview
D&MD's High-Growth Diagnostics: Technology and Market Analyses of Segments Experiencing Robust Growth in the Various Diagnostics Spaces market analysis report focuses on the market segments within the diagnostics industry that are currently experiencing robust growth. This also analyzes the technologies, markets (both qualitatively and quantitatively), and key companies within this space.
Questions Answered
> Qualitative trends-market drivers, market challenges, bottlenecks, opportunities-in selected high-growth diagnostics segments.
> Quantitative Analysis of Market Segments that together contribute to the growth of the diagnostics space.
> Organisms of importance (have wide market appeal) for infectious disease (ID) diagnostics to be built around.
> Agents of Bio Defense relevance for which diagnostics must be developed-another segment of market opportunity.
Market Opportunities
> Growth opportunity for tools developers to develop reagents, ASRs, technologies, hardware/instrumentation to address the diagnostics growth marketplace.
> Content companies can use this publication to ask where else they can invest.
> Diagnostics companies can use this publication to ask which diagnostics they can license-in, or in guidance to M&A transactions.
Jul-06 Pages 108
Table of Contents
Price
PDF $4,950.00
Printed $4,950.00
CD-ROM $4,950.00
Single Site Licence $6,930.00
Global Site Licence $7,425.00
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.